Published in
Wiley, British Journal of Haematology, 4(184), p. 536-546, 2018
DOI: 10.1111/bjh.15679
Links
Tools
Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma
Journal article published in 2018 by
Shaji K. Kumar 
,
Norbert Grzasko,
Sosana Delimpasi,
Wieslaw W. Jedrzejczak,
Sebastian Grosicki ,
Marie‐Christine Kyrtsonis,
Andrew Spencer,
Neeraj Gupta ,
Zhaoyang Teng,
Catriona Byrne,
Richard Labotka,
Meletios A. Dimopoulos
,
Norbert Grzasko,
Sosana Delimpasi,
Wieslaw W. Jedrzejczak,
Sebastian Grosicki ,
Marie‐Christine Kyrtsonis,
Andrew Spencer,
Neeraj Gupta ,
Zhaoyang Teng,
Catriona Byrne,
Richard Labotka,
Meletios A. Dimopoulos
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 